Navigation Links
Society of Gynecologic Oncologists to Host Cervical Cancer Prevention Forum
Date:9/9/2008

'The Future Strategies of Cervical Cancer Prevention: What Do We Need to Do Now to Prepare' Forum Facilitates Discussion on the Prevention of Cervical

Cancer in the HPV Vaccine Era

CHICAGO, Sept. 9 /PRNewswire/ -- The Society of Gynecologic Oncologists (SGO) is hosting a Cervical Cancer Prevention Forum on September 12-13, 2008 at the Hotel SAX in Chicago, IL. Approximately 50 key thought leaders will be in attendance to discuss the undefined areas of cervical cancer prevention, identify future research needs and establish follow-up initiatives for the future.

Since the introduction of the prophylactic HPV vaccines, healthcare providers have been faced with a host of questions and challenges concerning the clinical, public health, policy and economic issues regarding the prevention of cervical cancer. SGO, whose vision is "to eradicate gynecologic cancers", felt it was the opportune time to facilitate a larger discussion to answer these mounting questions and provide direction for the future.

"The HPV vaccine is a major technologic advance that has shown considerable promise in preventing the incidence of cervical cancer," states SGO President, Thomas Burke, MD. "As a result, we need to reevaluate the status of cervical cancer by identifying what is needed to more forward to eradicate this women's disease."

SGO invited key representatives from the various populations of clinicians, scientists, physicians and the public policy sector to participate in an informal, interactive discussion moderated by SGO members Levi Downs, MD, Mark Einstein, MD, Thomas Herzog, MD, Warner Huh, MD and Stewart Massad, MD.

"We believe the results of this meeting will have a tremendous impact on the future of cervical cancer prevention," asserts Dr. Herzog, Chair of the SGO Education Committee. "The Forum will redefine clinical, public health, policy and economic issues, as well as create a comprehensive summary to identify f
'/>"/>

SOURCE Society of Gynecologic Oncologists
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ApoA-I Data Presented at European Society of Cardiology Congress
2. TorreyPines Therapeutics to Present Tezampanel Phase IIb Clinical Data for Acute Migraine at 50th Annual Scientific Meeting of the American Headache Society
3. Breakthroughs Ahead, Endocrine Society Tells Security Analysts
4. The Leukemia & Lymphoma Society and Provid Pharmaceuticals Announce Collaboration on Treatment for Acute Myelogenous Leukemia
5. ProMetic announces Octapharma publication of PRDTS prion removal resin in Octaplas(R) manufacturing process at 30th International Congress of the International Society for Blood Transfusion meeting in Macao SAR, China
6. NanoLogix Inc. to Present at The American Society for Microbiology (ASM) General Meeting in Boston; Announces Product Line and Provides Operations Update
7. Elekta Sees Record Attendance and Record Number of Submitted Abstracts at International Leksell Gamma Knife(R) Society Meeting in Quebec, Canada
8. Board Certified Dermatologist and President-Elect of the Dermatologic Society of Greater New York, Dr. Lance H. Brown Takes His Comprehensive Practice to East Hampton, NY
9. Coalition for Pulmonary Fibrosis and American Thoracic Society Continue Research Partnership Through 2010
10. Sangamo BioSciences Announces Presentation of Phase 1 Data of ZFP Therapeutic at International Society for Cellular Therapy (ISCT) Meeting
11. Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 Cynvenio, a cancer diagnostics company ... genomic analysis of tumor cells in the bloodstream, today ... cancer decision support application powered by CollabRx, Inc. ... genomic test, Therapy Finder will provide breast cancer patients ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 This webinar ... nonclinical and clinical safety assessment in biosimilars. , Regulatory ... for biosimilar drug development, however the complex nature of ... quality, safety and efficacy extremely challenging. Based on the ...
(Date:1/15/2014)... 15, 2014 Two champions of science, ... sponsorship of an annual competition for middle and high ... to, innovative STEM study. The competition presents students with ... of Engineering Aptitude, Mathematics, and Sciences is a ...
(Date:1/15/2014)... Arizona (PRWEB) January 15, 2014 2013 ... for Scottsdale’s Brain State Technologies®. They saw continued independent ... Medical Center who were awarded a $1 million grant ... published in “Brain and Behavior” a peer reviewed journal, ...
Breaking Biology Technology:Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3
... Highlights Trends In eCTD Migration And Submissions Outsourcing And, Provides ... ... America And Europe, PHILADELPHIA and LONDON, July 17 ... its 2008,Liquent Regulatory Affairs Trends Survey. The survey attracted respondents,from across ...
... Johnson & Johnson Pharmaceutical,Research & Development, L.L.C. ... (FDA) Anti-Infective Drugs Advisory Committee voted in,favor of ... for,injection) for the treatment of hospital-acquired pneumonia, or ... committee voted that 500 mg of DORIBAX at ...
... BioMarin,Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced today ... Sankyo), has received marketing,approval from the Japanese Ministry ... extension of Biopten(R) (sapropterin dihydrochloride), which,contains the same ... the,treatment of patients with phenylketonuria (PKU). BioMarin will ...
Cached Biology Technology:The Scientific Business of Thomson Reuters Publishes Its 2008 Liquent Regulatory Affairs Trends Survey Results 2The Scientific Business of Thomson Reuters Publishes Its 2008 Liquent Regulatory Affairs Trends Survey Results 3FDA Advisory Committee Provides Opinion of DORIBAX(TM) for the Treatment of Hospital-Acquired Pneumonia 2FDA Advisory Committee Provides Opinion of DORIBAX(TM) for the Treatment of Hospital-Acquired Pneumonia 3FDA Advisory Committee Provides Opinion of DORIBAX(TM) for the Treatment of Hospital-Acquired Pneumonia 4Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU 2Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU 3Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU 4
(Date:7/9/2014)... are turning to more healthful alternatives to their savored ... mean low satisfaction. Now researchers are reporting new progress ... are made with olive oil rather than pork fat. ... Agricultural and Food Chemistry . , Ana M. Herrero ... expect just the right amount of chewiness and springiness, ...
(Date:7/9/2014)... census of Adlie penguins shows that the population ... larger than previously estimated. Adlie penguins have long ... and understand the effects of climate change and ... high-resolution satellite imagery, researchers from Stony Brook University ... method that permits regular monitoring of Adlie penguins ...
(Date:7/9/2014)... economy driven by methane, the primary component of natural gas, ... boom. It has poised the country as a top fuel ... just how climate-friendly it is, according to an article in ... magazine of the American Chemical Society. , In the article, ... burned as a fuel to produce electricity, methane emits about ...
Breaking Biology News(10 mins):New study finds that Adélie penguin population is on the rise 2New study finds that Adélie penguin population is on the rise 3
... (FDA) today approved Symlin, an injectable medicine to control blood ... Symlin is to be used in addition to insulin therapy ... sugars on intensive insulin therapy alone. , Symlin will be ... other than insulin. Patients with type 2 diabetes already have ...
... of Liverpool have discovered how fish have evolved over ... different water depths. , A research team led by ... of Biological Sciences, has revealed how modern fish, such ... floating at certain water levels using a gas-filled swimbladder. ...
... Genomed-Health 2005 workshop in Tunisia, supported by the ... sciences in improving health in countries bordering the ... the importance of Euro-Mediterranean partnerships in order to ... ?in particular following the mapping of the human ...
Cached Biology News:FDA Approves New Drug to Treat Type I and Type II Diabetes 2Scientists discover how fish evolved to float at different sea depths 2Measuring the impact of post-genomics on Mediterranean populations 2
... fromStreptomyces griseolusthat inhibits protein synthesis. Acts ... eukaryote ribosomes. Reported to induce apoptosis ... promyelocytic leukemia cells, Jurkat cells, ventricular ... intracellular signals and immediate early gene ...
The VersArray hybridization chamber is used for manual (coverslip) hybridization of microarrays. The chamber accommodates 2 slides and is watertight to allow incubation of slides in a water bath. Dim...
... Eclipse is a state-of-the-art separation system using ... technique. The Eclipse integrates easily with Wyatts ... Tristar, as well as the Optilab DSP. ... molar mass distributions of the particles/molecules separated ...
Monoclonal antibodies conjugated with rhodamine...
Biology Products: